Dear Friends,
New this week!
I am continuing my countdown of the top 10 ASCO abstracts related to CLL.
Here are numbers 6 and 5.
The combination of acalabrutinib and obinituzumab proved to be well tolerated and very effective in all stages of CLL. Watch my review of this research here.
cllsociety.org/2019/12/asco...
CAR-T therapy has significant side effects and risks, but it knocks back the CLL in most patients. Here is my video review of this important ASCO abstract on CAR-T. We will be updating this using the data set from ASH early in 2020.
cllsociety.org/2019/12/asco...
The CLL Society Tribune has been released!
Our Fourth 2019 issue of The CLL Society Tribune has just been released! This quarter’s issue brings you the latest news, answers to your questions from our Medical Advisory Board, research, stories, and creative efforts shared by patients and caregivers.
Among other things, don’t miss my wife, Patty Koffman’s famous Cajun Gingerbread recipe just in time for the holidays, Dr. Pleyer on vaccinations in CLL, my 4 psychological tips, Dr. LeClair on normal lab values, Brian Maxson and Cathy Jensen sharing life lessons, and so much more.
cllsociety.org/quarter-4-20...
Stay strong.
We are all in this together.
Brian
Brian Koffman MDCM (retired) MS Ed
Co-Founder, Executive VP and Chief Medical Officer
CLL Society, Inc
